http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008523084-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate | 2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008523084-A |
| titleOfInvention | Immunostimulating combination and method |
| abstract | The present invention provides an immunostimulatory combination and a method for enhancing TLR8-mediated biological activity. In general, an immunostimulatory combination includes a TLR8 agonist and an amount of an immunostimulatory oligonucleotide effective to enhance TLR8-mediated biological activity. The invention also provides a method for inducing TLR8-mediated biological activity in immune cells. In general, the method comprises contacting an immune cell with an immunostimulatory combination comprising a TLR8 agonist and an amount of an immunostimulatory oligonucleotide effective to enhance TLR8-mediated biological activity. In some cases, the immunostimulatory combination provides a synergistic increase in TLR8-mediated biological activity. |
| priorityDate | 2004-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 267.